Multicenter Uveitis Steroid Treatment Trial - MUST

ational Institutes of Health, National Eye Institute0 个研究点目标入组 250 人开始时间: 2008年1月18日最近更新: 2019年11月25日

适应症

试验速览

暂无简介。

•- Age 18+
•- Diagnosis of non-infectious intermediate uveitis, posterior uveitis or panuveitis
•- Active uveitis of a degree for which systemic corticosteroid therapy is indicated
•- Best-corrected visual acuity of hand motions or better
•- Baseline intraocular pressure of 24 mm Hg or less
•Note that the international protocol allows for enrollment of patients of 13+ years, but in the UK we have not and will not seek approval to recruit anyone under 18.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•- Inadequately controlled diabetes mellitus
•- Known allergy to study medication
•- Uncontrolled glaucoma
•- Advanced glaucomatous optic nerve injury
•- A history of scleritis (concern of scleral melting)
•- Pregnancy or breast-feeding
•- HIV infection or other immundeficiency disease for which steroids would be contraindicated

发起方

ational Institutes of Health, National Eye Institute